Asset Details
Do you wish to reserve the book?
On-site reactor for treating source-separated human urine with sparingly soluble fumaric acid in building-scale sanitation systems
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
On-site reactor for treating source-separated human urine with sparingly soluble fumaric acid in building-scale sanitation systems
Do you wish to request the book?
On-site reactor for treating source-separated human urine with sparingly soluble fumaric acid in building-scale sanitation systems
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
On-site reactor for treating source-separated human urine with sparingly soluble fumaric acid in building-scale sanitation systems
2025
Overview
To complement innovations at the front- and back-ends of source-separating sanitation systems, this study demonstrates a novel approach for stabilising human urine using sparingly soluble fumaric acid. A reactor was developed to dose fumaric acid passively into freshly excreted urine and was operated to mimic more than 250 typical urination events over 15 days. Fumaric acid at a dose of 5.6 g L -1 effectively maintained urine pH below 4.0, inhibiting enzymatic urea hydrolysis and preventing the precipitation of alkaline earth metals and phosphates, thereby protecting downstream infrastructure from blockages. The stabilised urine retained all its constituents, except for 20% of the sulphate. Novel UV-Vis monitoring techniques were introduced to track fumaric acid depletion (ΔAbs221) and solids settling rate (ΔAbs660), and were demonstrated to be practical surrogates for assessing real-time reactor performance. With an estimated operating cost of less than US$ 5 per person per year, this reactor provides a simple, cost-effective, and scalable solution for stabilising urine in decentralised settings.
Publisher
Frontiers Media S.A
